Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3t99 | ADP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3t99 | ADP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 1.000 | |
| 3t9a | ANP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.620 | |
| 4nzo | ANP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.565 | |
| 3t9f | ADP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.563 | |
| 3t9e | ADP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.560 | |
| 3t9d | ANP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.558 | |
| 3t54 | ATP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.548 | |
| 4q4c | ADP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.534 | |
| 2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.490 | |
| 2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.482 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
| 4fzv | SAM | 5-methylcytosine rRNA methyltransferase NSUN4 | 2.1.1 | 0.467 | |
| 2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.466 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.463 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.461 | |
| 2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.460 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
| 2cdu | FAD | NADH oxidase | / | 0.458 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 1f8w | FAD | NADH peroxidase | 1.11.1.1 | 0.454 | |
| 1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 1w49 | APC | NTPase P4 | / | 0.453 | |
| 1u8v | FAD | 4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase | / | 0.452 | |
| 4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.452 | |
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 2yxl | SFG | 450aa long hypothetical fmu protein | / | 0.449 | |
| 3r8v | Z62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 4a6c | QG9 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
| 1nhr | FAD | NADH peroxidase | 1.11.1.1 | 0.448 | |
| 2nli | FMN | Lactate oxidase | / | 0.448 | |
| 3ggu | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 4gyi | ADP | Uncharacterized protein | / | 0.447 | |
| 3vfa | 031 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 3el5 | 1UN | Gag-Pol polyprotein | / | 0.444 | |
| 1bv9 | XV6 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 2pym | 1UN | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
| 3wo1 | ADP | Alanine--anticapsin ligase | / | 0.443 | |
| 1d4j | MSC | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 1npv | L27 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 5kgp | ACO | Predicted acetyltransferase | / | 0.442 | |
| 1osv | CHC | Bile acid receptor | / | 0.441 | |
| 1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.440 | |
| 1nzd | UPG | DNA beta-glucosyltransferase | / | 0.440 |